Diabetes is characterized by chronic systemic hyperglycemia, which activates several secondary metabolic pathwayssuch as the polyol pathway, accumulation of AGE products, and protein kinase C (PKC) activationthat contribute to retinal and systemic vascular damage [67]
Our clinic offers sleep assessments to monitor patient progress while on GLP-1 therapy, helping individuals potentially reduce CPAP dependence and achieve restful sleep
Typically, patients can begin to notice changes within 4 to 6 weeks of starting treatment, but the most noticeable weight loss typically occurs after 8 to 12 weeks
As a proud clinical research site for this study, the team at MediSphere is thrilled to have played a direct role in conducting these trials and bringing this revolutionary, convenient daily pill to the patients who need it most
Employer benefits plans vary widely in obesity medication coverage
Tirzepatide was generally well tolerated and had a low risk of hypoglycaemia